From: T1 mapping and T2 mapping at 3T for quantifying the area-at-risk in reperfused STEMI patients
 | ICC (95 % CI) | Mean difference ± SD (%) | P |
---|---|---|---|
Intra-observer variability (n = 107) |  | ||
T1 mapping | Â | Â | Â |
Manual | 0.961 (0.943 – 0.973) | 1.5 ± 7.1 | 0.04* |
2SD | 0.948 (0.917 – 0.966) | 2.6 ± 7.7 | 0.001* |
Otsu | 0.989 (0.984 – 0.993) | 0.7 ± 3.2 | 0.03* |
T2 mapping | Â | Â | Â |
Manual | 0.951 (0.928 – 0.966) | 0.8 ± 6.4 | 0.18 |
2SD | 0.965 (0.942 – 0.978) | 2.4 ± 6.4 | 0.001* |
Otsu | 0.996 (0.995 – 0.998) | 0.2 ± 1.9 | 0.24 |
Inter-observer variability (n = 107) |  | ||
T1 mapping | Â | Â | Â |
Manual | 0.980 (0.972 – 0.987) | 0.3 ± 4.3 | 0.52 |
2SD | 0.948 (0.925 – 0.964) | 3.7 ± 7.2 | 0.001* |
Otsu | 0.993 (0.990 – 0.995) | 0.2 ± 2.6 | 0.55 |
T2 mapping | Â | Â | Â |
Manual | 0.964 (0.947 – 0.975) | 0.3 ± 6.1 | 0.59 |
2SD | 0.960 (0.914 – 0.978) | 3.5 ± 6.5 | 0.001* |
Otsu | 0.993 (0.989 – 0.995) | 0.7 ± 2.6 | 0.008* |